P1/2, N=15, Terminated, Evaxion Biotech A/S | Active, not recruiting --> Terminated; Based on the promising interim results of study part 1, it was decided to further accelerate the development of the 2nd generation DNA plasmid immunotherapy. Therefore enrolment of patients was completed after study part 1
9 months ago
Trial termination • Metastases
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)